Amgen has been in pullback mode since the beginning of February, losing roughly 13% within the context of its long-term uptrend. For those interested in "buying the dip," this may be a good time to revisit the stock, noting the decline looks overdone in the short term. There has been a positive reaction from AMGN to a short-term counter-trend "buy" signal from Tom DeMARK's TD Combo model, which supports a minimum two-week bounce. With Friday's reversal bar on AMGN's daily chart, combined with today's strength, our preferred momentum indicator the daily MACD is back on a "buy" signal. The MACD also shows a positive short-term divergence, supporting a bigger relief rally for AMGN in the near term.

---

Persons: Amgen, Tom DeMARK's Organizations: AMGN